Outcomes for SAD markers | Unstandardized β | Standardized β | 95% CI | P value |
---|---|---|---|---|
CT | Â | Â | Â | Â |
 LAA−950, % | 0.64 | 0.07 | − 0.07, 1.34 | 0.078 |
 LAA−856, % | 6.12 | 0.21 | 4.13, 8.14 |  < 0.001 |
 RV, L | 0.16 | 0.11 | 0.05, 0.26 | 0.003 |
 TLC, L | − 0.17 | − 0.11 | − 0.28, − 0.07 | 0.001 |
IOS | Â | Â | Â | Â |
 R5, Ka/L/s | 0.01 | 0.04 | − 0.01, 0.02 | 0.382 |
 R20, Ka/L/s | − 0.00 | − 0.01 | − 0.01, 0.01 | 0.755 |
 R5–R20, Ka/L/s | 0.01 | 0.07 | − 0.00, 0.01 | 0.116 |
 X5, Ka/L/s | − 0.02 | − 0.16 | − 0.03, − 0.01 |  < 0.001 |
 AX, Ka/L | 0.18 | 0.12 | 0.06,0.30 | 0.004 |
 Fres, Hz | 0.80 | 0.14 | 0.32,1.29 | 0.001 |
Postbronchodilator | Â | Â | Â | Â |
 MMEF, %predicted | − 6.17 | − 0.22 | − 8.20, − 4.13 |  < 0.001 |
 FEF50, %predicted | − 7.01 | − 0.22 | − 9.31, − 4.72 |  < 0.001 |
 FEF75, %predicted | − 4.02 | − 0.15 | − 6.20, − 1.84 |  < 0.001 |